miltefosine has been researched along with Epithelial Neoplasms in 2 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erukulla, RK | 1 |
| Zhou, X | 1 |
| Samadder, P | 1 |
| Arthur, G | 1 |
| Bittman, R | 1 |
| Ruiter, GA | 1 |
| Zerp, SF | 1 |
| Bartelink, H | 1 |
| van Blitterswijk, WJ | 1 |
| Verheij, M | 1 |
2 other studies available for miltefosine and Epithelial Neoplasms
| Article | Year |
|---|---|
Synthesis and evaluation of the antiproliferative effects of 1-O-hexadecyl-2-O-methyl-3-O-(2'-acetamido-2'-deoxy-beta-D- glucopyranosyl)-sn-glycerol and 1-O-hexadecyl-2-O-methyl-3-0- (2'-amino-2'-deoxy-beta-D-glucopyranosyl)-sn-glycerol on epithelial canc
Topics: Antineoplastic Agents; Cell Division; Diglycerides; Glycolipids; Humans; Molecular Structure; Neopla | 1996 |
Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathway.
Topics: Antineoplastic Agents; Apoptosis; Dose-Response Relationship, Drug; Growth Inhibitors; HeLa Cells; H | 2003 |